GB201406989D0 - Novel treatments - Google Patents

Novel treatments

Info

Publication number
GB201406989D0
GB201406989D0 GBGB1406989.2A GB201406989A GB201406989D0 GB 201406989 D0 GB201406989 D0 GB 201406989D0 GB 201406989 A GB201406989 A GB 201406989A GB 201406989 D0 GB201406989 D0 GB 201406989D0
Authority
GB
United Kingdom
Prior art keywords
novel treatments
treatments
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1406989.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Follicum AB
Original Assignee
Follicum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Follicum AB filed Critical Follicum AB
Priority to GBGB1406989.2A priority Critical patent/GB201406989D0/en
Publication of GB201406989D0 publication Critical patent/GB201406989D0/en
Priority to BR112016023899A priority patent/BR112016023899A2/pt
Priority to MX2016013589A priority patent/MX2016013589A/es
Priority to CA2945930A priority patent/CA2945930A1/en
Priority to JP2016562948A priority patent/JP2017513856A/ja
Priority to PCT/GB2015/051165 priority patent/WO2015159099A1/en
Priority to KR1020167027851A priority patent/KR20160136342A/ko
Priority to SG11201608497YA priority patent/SG11201608497YA/en
Priority to AU2015248652A priority patent/AU2015248652A1/en
Priority to RU2016144971A priority patent/RU2016144971A/ru
Priority to CN201580019288.XA priority patent/CN106413734A/zh
Priority to US15/300,056 priority patent/US20170143605A1/en
Priority to EP15721789.4A priority patent/EP3131528A1/en
Priority to IL248084A priority patent/IL248084A0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
GBGB1406989.2A 2014-04-17 2014-04-17 Novel treatments Ceased GB201406989D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1406989.2A GB201406989D0 (en) 2014-04-17 2014-04-17 Novel treatments
EP15721789.4A EP3131528A1 (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth
KR1020167027851A KR20160136342A (ko) 2014-04-17 2015-04-17 모발 성장의 억제를 위한 오스테오폰틴 유도체를 포함하는 조성물
AU2015248652A AU2015248652A1 (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth
CA2945930A CA2945930A1 (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth
JP2016562948A JP2017513856A (ja) 2014-04-17 2015-04-17 毛成長抑制のためのオステオポンチン誘導体を含む組成物
PCT/GB2015/051165 WO2015159099A1 (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth
BR112016023899A BR112016023899A2 (pt) 2014-04-17 2015-04-17 composições compreendendo derivados de osteopontina para a inibição do crescimento do cabelo
SG11201608497YA SG11201608497YA (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth
MX2016013589A MX2016013589A (es) 2014-04-17 2015-04-17 Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo.
RU2016144971A RU2016144971A (ru) 2014-04-17 2015-04-17 Композиции, содержащие производные остеопонтина для ингибирования роста волос
CN201580019288.XA CN106413734A (zh) 2014-04-17 2015-04-17 用于抑制毛发生长的包含骨桥蛋白衍生物的组合物
US15/300,056 US20170143605A1 (en) 2014-04-17 2015-04-17 Compositions Comprising Osteopontin Derivatives for the Inhibition of Hair Growth
IL248084A IL248084A0 (en) 2014-04-17 2016-09-27 Preparations include osteopontin derivatives to prevent hair growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1406989.2A GB201406989D0 (en) 2014-04-17 2014-04-17 Novel treatments

Publications (1)

Publication Number Publication Date
GB201406989D0 true GB201406989D0 (en) 2014-06-04

Family

ID=50928957

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1406989.2A Ceased GB201406989D0 (en) 2014-04-17 2014-04-17 Novel treatments

Country Status (14)

Country Link
US (1) US20170143605A1 (enExample)
EP (1) EP3131528A1 (enExample)
JP (1) JP2017513856A (enExample)
KR (1) KR20160136342A (enExample)
CN (1) CN106413734A (enExample)
AU (1) AU2015248652A1 (enExample)
BR (1) BR112016023899A2 (enExample)
CA (1) CA2945930A1 (enExample)
GB (1) GB201406989D0 (enExample)
IL (1) IL248084A0 (enExample)
MX (1) MX2016013589A (enExample)
RU (1) RU2016144971A (enExample)
SG (1) SG11201608497YA (enExample)
WO (1) WO2015159099A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018202870A1 (en) * 2017-05-04 2018-11-08 Follicum Ab Peptides for treatment of diabetes
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
JP7553115B2 (ja) * 2018-11-07 2024-09-18 フォリクム エービー 糖尿病治療のためのペプチド断片
WO2020161255A1 (en) * 2019-02-07 2020-08-13 Dsm Ip Assets B.V. Novel method for reducing hair growth
EP3692978A1 (en) * 2019-02-07 2020-08-12 DSM IP Assets B.V. Novel method
US20220273765A1 (en) * 2019-04-24 2022-09-01 Follicum Ab Topical formulation
CA3168454A1 (en) 2020-02-25 2021-09-02 David K. Rosen Compositions and methods for stimulating hair growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
JP5043253B2 (ja) * 1999-10-21 2012-10-10 花王株式会社 脱毛剤及び外用剤
DE60131525T2 (de) * 2000-03-23 2008-09-25 Glaxo Group Ltd., Greenford Verfahren zum screening von inhibitoren für osteopontin
WO2008086449A2 (en) * 2007-01-09 2008-07-17 Oregon Health & Science University Synthetic osteopontin peptides and methods of use
GB2493540A (en) * 2011-08-10 2013-02-13 Follicum Ab Agents for stimulating hair growth in mammals

Also Published As

Publication number Publication date
US20170143605A1 (en) 2017-05-25
RU2016144971A3 (enExample) 2018-11-30
KR20160136342A (ko) 2016-11-29
EP3131528A1 (en) 2017-02-22
BR112016023899A2 (pt) 2018-06-05
RU2016144971A (ru) 2018-05-17
SG11201608497YA (en) 2016-11-29
CN106413734A (zh) 2017-02-15
MX2016013589A (es) 2017-07-04
IL248084A0 (en) 2016-11-30
CA2945930A1 (en) 2015-10-22
JP2017513856A (ja) 2017-06-01
AU2015248652A1 (en) 2016-10-20
WO2015159099A1 (en) 2015-10-22

Similar Documents

Publication Publication Date Title
AU361515S (en) Dishrack
AU362944S (en) Lapboard
IL248856B (en) New treatment
PT3099317T (pt) Tripsina de bacalhau para utilização no tratamento de infeções microbianas num indivíduo com imunodeficiência
GB201406989D0 (en) Novel treatments
GB201412011D0 (en) Treatments
GB201411027D0 (en) Treatment
GB201412411D0 (en) Treatment
GB201414542D0 (en) Novel therapy
GB201401480D0 (en) Novel treatments
AU5594P (en) Lanoregon Mandevilla sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi
AU5285P (en) FLOMANRER Mandevilla sanderi
AU5286P (en) FLOMANWHW Mandevilla sanderi
AU5288P (en) FLOMANTOG Mandevilla sanderi
AU5287P (en) FLOMANPIW Mandevilla sanderi
AU5289P (en) FLOMANFOP Mandevilla sanderi
GB201413317D0 (en) Atheroscierosis treatment
GB201412410D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)